Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nuclear Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.nucmedbio.2016.10.002PMID 27837727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography

  2016cited by this paper
• Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase.

  2016cited by this paper
• Inhibitors of tissue transglutaminase.

  2015cited by this paper
• Elevated transglutaminase 2 activity is associated with hypoxia-induced experimental pulmonary hypertension in mice.

  2014cited by this paper
• Tissue transglutaminase: an emerging target for therapy and imaging.

  2013cited by this paper
• Role of transglutaminase 2 in celiac disease pathogenesis

  2012cited by this paper
• Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype

  2012cited by this paper
• Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells

  2012cited by this paper
• SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.

  2012cited by this paper
• Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

  2012cited by this paper
• Transglutaminase 2 and its role in pulmonary fibrosis.

  2011cited by this paper
• Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.

  2011cited by this paper
• A Profiling Platform for the Characterization of Transglutaminase 2 (TG2) Inhibitors

  2010cited by this paper
• Applications of LC-MS in PET radioligand development and metabolic elucidation.

  2010cited by this paper
• Redox Regulation of Transglutaminase 2 Activity*

  2010cited by this paper
• PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

  2009cited by this paper
• Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.

  2008cited by this paper
• Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.

  2008cited by this paper
• A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma.

  2007cited by this paper
• Transglutaminase 2 Undergoes a Large Conformational Change upon Activation

  2007cited by this paper
• Production of [11C]chloroform by direct chlorination of [11C]methane without catalyst support for the synthesis of [11C]diazomethane.

  2007cited by this paper
• Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease.

  2007cited by this paper
• Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.

  2006cited by this paper
• Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer

  2004cited by this paper
• Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

  2004cited by this paper
• Transglutaminases: crosslinking enzymes with pleiotropic functions

  2003cited by this paper
• Transglutaminase 2: an enigmatic enzyme with diverse functions.

  2002cited by this paper
• Transglutaminases: nature's biological glues.

  2002cited by this paper
• Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity

  2002cited by this paper
• A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system

  2001cited by this paper
• A sensitive fluorometric assay for tissue transglutaminase.

  2001cited by this paper
• Inaugural Article: Positron emission tomography provides molecular imaging of biological processes

  2000cited by this paper
• 2‐[18F]fluoropyridines by no‐carrier‐added nucleophilic aromatic substitution with [18F]FK‐K222—a comparative study

  1999cited by this paper
• The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

  1997cited by this paper
• Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.

  1996cited by this paper
• Fluoroacylation agents based on small n.c.a. [18F]fluorocarboxylic acids

  1994cited by this paper
• One-step synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling.

  1994cited by this paper
• Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.

  1992cited by this paper
• Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR‐13119

  1989cited by this paper
• Synthesis of carbon-11 labelled diazomethane

  1987cited by this paper

• SPECT as a translational non-invasive method to assess occupancy of the tissue transglutaminase-2 by zampilimab in the mouse lung.

  2026cites this paper
• Tissue transglutaminase inhibitors over the past decade.

  2025cites this paper
• Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2

  2024cites this paper
• Absence of tissue transglutaminase reduces amyloid‐beta pathology in APP23 mice

  2022cites this paper
• Molecular Imaging of Autoimmune Diseases

  2021cites this paper
• Development of an 18F-Labeled Irreversible Inhibitor of Transglutaminase 2 as Radiometric Tool for Quantitative Expression Profiling in Cells and Tissues.

  2021cites this paper
• Transglutaminase 2 as a novel target in chronic kidney disease - Methods, mechanisms and pharmacological inhibition.

  2020cites this paper
• Characterization of Tissue Transglutaminase as a Potential Biomarker for Tissue Response toward Biomaterials.

  2019cites this paper
• In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model

  2018influential citation
• The diamond anniversary of tissue transglutaminase: a protein of many talents.

  2018cites this paper